Company profile for 4D Molecular Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

4DMT is a gene therapy company with a transformative discovery platform—Therapeutic Vector Evolution—that enables our “disease first” approach to product discovery and development, thereby allowing us to customize our AAV vectors to target specific tissue types associated with the underlying disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5858 Horton St. Suite 455 Emeryville, CA 94608
Telephone
Telephone
(510) 505-2680
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/20/3191851/0/en/4DMT-to-Participate-in-8th-Annual-Evercore-Healthcare-Conference.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/17/3188927/0/en/4DMT-Appoints-Kristian-Humer-as-Chief-Financial-Officer.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/14/3188599/0/en/4DMT-Announces-New-Employment-Inducement-Grants.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184478/0/en/4DMT-Reports-Third-Quarter-2025-Financial-Results-Operational-Highlights-and-Expected-Upcoming-Milestones.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183115/0/en/4DMT-to-Participate-in-Jefferies-2025-London-Healthcare-Conference.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/10/31/3178071/0/en/4DMT-Announces-Exclusive-License-Agreement-with-Otsuka-Pharmaceutical-Co-Ltd-for-Development-and-Commercialization-of-4D-150-in-Asia-Pacific.html

GLOBENEWSWIRE
30 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty